Viroclinics is a virology contract research organization that provides non-clinical and clinical services for the vaccine development market. Read more

1 Followers on Owler
1 Followers on Owler
1 Followers on Owler
1 Followers on Owler

Viroclinics is a virology contract research organization that provides non-clinical and clinical services for the vaccine development market. Read more

Bob van Gemen's photo - CEO of Viroclinics Biosciences B.V

CEO

Bob van Gemen

CEO Approval Rating

70/100

Founded:

2001

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

CROMSOURCE is seen as one of Viroclinics Biosciences B.V's top competitors. CROMSOURCE was founded in Verona, Veneto} in 1997. CROMSOURCE is in the Medical Research & Laboratories industry. Compared to Viroclinics Biosciences B.V, CROMSOURCE generates $120M more revenue.

QPS is Viroclinics Biosciences B.V's #2 competitor. QPS was founded in 1995, and its headquarters is in Newark, Delaware. QPS competes in the Medical Research & Laboratories industry. QPS has 990 more employees than Viroclinics Biosciences B.V.

CTI is Viroclinics Biosciences B.V's #3 rival. CTI is headquartered in Covington, Kentucky, and was founded in 1999. CTI operates in the Health Care Services industry. CTI generates ∞% the revenue of Viroclinics Biosciences B.V.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 240 a good estimate for Viroclinics Biosciences B.V's Employee count?

Acquisitions

No recent acquisitions found related to Viroclinics Biosciences B.V

Viroclinics Biosciences B.V Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Mar 2020
--

Summit Partners

Since Viroclinics Biosciences B.V was founded in 2001, it has participated in 1 round of funding. In total Viroclinics Biosciences B.V has raised $0. Viroclinics Biosciences B.V's funding round was on Mar 2020 for a total of $0

Investments

No recent investments found related to Viroclinics Biosciences B.V

Viroclinics Biosciences B.V News

April 9, 2020Pharamceutical Technology

UQ Covid-19 vaccine candidate advances to preclinical tests

The University of Queensland (UQ) in Australia has progressed its Covid-19 vaccine candidate into pre... See more »
March 6, 2020Unquote

Summit-backed Viroclinics acquires DDL | Unquote

Bob van Gemen, CEO of Viroclinics Biosciences, will serve as CEO of the combined organisation... See more »
March 6, 2020Biospectrum Asia

Viroclinics Biosciences and DDL Diagnostic Lab join forces

Viroclinics Biosciences and DDL Diagnostic Laboratory Join Forces... See more »
March 3, 2020BioSpace

Summit Partners Announces Growth Equity Investment in Viroclinics Biosciences

Global growth equity investor Summit Partners today announced a majority investment in Viroclinics Bi... See more »
March 3, 2020Clinical Lab Products

Viroclinics Biosciences and DDL Diagnostic Laboratory Join Forces

The transaction enhances the combined group's leading global position in antiviral and vaccine testin... See more »
September 4, 2017FinSMEs

Parcom Capital Acquires Viroclinics

Viroclinics, a Rotterdam, The Netherlands-based clinical research organization, was acquired by Parco... See more »
August 30, 2017Center Watch

Parcom Capital acquires Viroclinics Biosciences

Viroclinics, founded in 2001 and specializing in testing new vaccines and drugs in the clinical trial... See more »

Viroclinics Biosciences B.V Press Releases

Viroclinics Biosciences B.V Videos

Social Media

Headquarters

Marconistraat 16

Rotterdam, Noord-Holland3029

31-88-668-4787

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Viroclinics is a virology contract research organization that provides non-clinical and clinical services for the vaccine development market. Viroclinics Biosciences B.V was founded in 2001. Viroclinics Biosciences B.V's headquarters is located in Rot...

CEO

Viroclinics Biosciences B.V's CEO, Bob van Gemen, currently has an approval rating of 70%. Viroclinics Biosciences B.V's primary competitors are CROMSOURCE, QPS & CTI.

Website

viroclinics.eu

Frequently Asked Questions about Viroclinics Biosciences B.V

  1. When was Viroclinics Biosciences B.V founded?

    Viroclinics Biosciences B.V was founded in 2001
  2. Who is Viroclinics Biosciences B.V's CEO?

    Viroclinics Biosciences B.V's CEO is Bob van Gemen
  3. How much revenue does Viroclinics Biosciences B.V generate?

    Viroclinics Biosciences B.V generates $ < 1M in revenue
  4. How much funding does Viroclinics Biosciences B.V have?

    Viroclinics Biosciences B.V has historically raised $0 in funding
  1. Where is Viroclinics Biosciences B.V's headquarters?

    Viroclinics Biosciences B.V's headquarters is in Rotterdam Noord-Holland, NL
  2. How many employees does Viroclinics Biosciences B.V have?

    Viroclinics Biosciences B.V has 240 employees
  3. What sector does Viroclinics Biosciences B.V operate in?

    Viroclinics Biosciences B.V is in Medical Research & Laboratories
  4. Who are Viroclinics Biosciences B.V's competitors?

    Viroclinics Biosciences B.V's top competitors are CROMSOURCE, QPS, CTI